0HUZ.L

Celsion Corporation [0HUZ.L] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

0HUZ.L Stock Summary

In the News

0HUZ.L Financial details

Company Rating
-
Market Cap
14.33M
Income
-19.51M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
0.18
Dividend %
27.38%
Employees
33
Optionable
No
Shortable
Yes
Earnings
09 May 2024
P/E
-0.22
Forward P/E
-
PEG
0.04
P/S
50
P/B
0.35
P/C
-
P/FCF
-0.3
Quick Ratio
3.64
Current Ratio
4.09
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-2.18
EPS next Y
-
EPS next Q
-
EPS this Y
-57.06%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-28.53%
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
40.54%
-
-
-
-
SMA20
8.33%
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-113%
ROE
-117%
ROC
-1.14%
Gross Margin
-8491%
Oper. Margin
-17592%
Profit Margin
-22288%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.49428-1.53
52W High
-
52W Low
-
RSI
49.05
Rel Volume
0.14
Avg Volume
2.35K
Volume
330
Perf Week
0.01%
Perf Month
9.44%
Perf Quarter
-
Perf Half Y
-5.64%
-
-
-
-
Beta
2.008
-
-
Volatility
0.04%, 0.06%
Prev Close
-5.44%
Price
0.8801
Change
-5.44%

0HUZ.L Financial Performance

0HUZ.L Dividend History

0HUZ.L Frequently Asked Questions

What is Celsion Corporation stock symbol ?

Celsion Corporation is a US stock , located in Lawrenceville of Nj and trading under the symbol 0HUZ.L

What is Celsion Corporation stock quote today ?

Celsion Corporation stock price is $0.8801 today.

Is Celsion Corporation stock public?

Yes, Celsion Corporation is a publicly traded company.

Something similar

Top by Market Cap
TSLA
GOOGL
3V64.DE
1YD.DE
FXAIX
Same Sector
PPD
EPRX.TO
FRLN
ODTC
GHP.ST
Check Those
PAHC
FINX
TZPSW
0224.HK
4323.T
Similar Market Cap
CLWT
CNFR
DMTK
HCGI
SDRC

Company Profile

Healthcare Medical - Pharmaceuticals
  • Volume Average 2.35K
  • Market Capitalization 14.33M
  • Employee 33
  • CEO Mr. Michael H. Tardugno
  • Headquarters Lawrenceville,NJ,US
  • IPO Date 2018-01-29
  • Website https://celsion.com

Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey.